153 related articles for article (PubMed ID: 28529618)
1. Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status.
Hayashi N; Iwamoto T; Qi Y; Niikura N; Santarpia L; Yamauchi H; Nakamura S; Hortobagyi GN; Pusztai L; Symmans WF; Ueno NT
J Cancer; 2017; 8(6):1045-1052. PubMed ID: 28529618
[No Abstract] [Full Text] [Related]
2. Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.
Shen Q; Sahin AA; Hess KR; Suki D; Aldape KD; Sawaya R; Ibrahim NK
Oncologist; 2015 May; 20(5):466-73. PubMed ID: 25802405
[TBL] [Abstract][Full Text] [Related]
3. Radiomic Signatures for Predicting Receptor Status in Breast Cancer Brain Metastases.
Luo X; Xie H; Yang Y; Zhang C; Zhang Y; Li Y; Yang Q; Wang D; Luo Y; Mai Z; Xie C; Yin S
Front Oncol; 2022; 12():878388. PubMed ID: 35734585
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance.
Kotecha R; Tonse R; Rubens M; McDermott MW; Odia Y; Appel H; Mehta MP
Neurooncol Adv; 2021; 3(1):vdab010. PubMed ID: 33898990
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular biomarker identification in breast cancer brain metastases.
Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
[TBL] [Abstract][Full Text] [Related]
6. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
7. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.
Lee JY; Park K; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Hong M; Do IG; Ahn T; Lee SK; Bae SY; Kim SW; Lee JE; Nam SJ; Kim DH; Jung HH; Kim JY; Ahn JS; Im YH; Park YH
Oncotarget; 2015 Dec; 6(41):43731-42. PubMed ID: 26527317
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
9. Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.
Jung J; Lee SH; Park M; Youn JH; Shin SH; Gwak HS; Yoo H
J Neurooncol; 2018 Apr; 137(2):295-302. PubMed ID: 29260362
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling of Breast Cancer Brain Metastasis.
Lee JY; Park K; Lee E; Ahn T; Jung HH; Lim SH; Hong M; Do IG; Cho EY; Kim DH; Kim JY; Ahn JS; Im YH; Park YH
Sci Rep; 2016 Jun; 6():28623. PubMed ID: 27340107
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
12. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
14. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
Leone JP; Lee AV; Brufsky AM
Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
[TBL] [Abstract][Full Text] [Related]
16.
Xie N; Tian C; Wu H; Yang X; Liu L; Li J; Xiao H; Gao J; Lu J; Hu X; Cao M; Shui Z; Tang Y; Wang X; Yang J; Hu ZY; Ouyang Q
Ther Adv Med Oncol; 2020; 12():1758835920915305. PubMed ID: 32499836
[TBL] [Abstract][Full Text] [Related]
17. Gene expression signature of estrogen receptor alpha status in breast cancer.
Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
[TBL] [Abstract][Full Text] [Related]
18. ER
Arciero CA; Guo Y; Jiang R; Behera M; O'Regan R; Peng L; Li X
Clin Breast Cancer; 2019 Aug; 19(4):236-245. PubMed ID: 30846407
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates and other bone agents for breast cancer.
Wong MH; Stockler MR; Pavlakis N
Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
[TBL] [Abstract][Full Text] [Related]
20. Assessment of topoisomerase II-alpha gene status by dual color chromogenic
Neama RAA; Habib MA; Ali SA; Al-Khafaji AH; Alqanbar MF
Indian J Pathol Microbiol; 2017; 60(4):475-480. PubMed ID: 29323058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]